Add to ORKGThe advent of highly active antiretroviral therapy (HAART) has lead to a substantial reduction in the prevalence, morbidity, and mortality associated with AIDS-related Kaposi\u27s sarcoma. Similarly, concomitant advances in chemotherapy and supportive-care
The clinical response of AIDS-related Kaposi's sarcoma (KS) to highly active antiretroviral therapy ...
Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its appearance on t...
A 42-year-old heterosexual man presented with bluish-purple spots on his skin and in his mouth cavit...
Kaposi's sarcoma (KS) is the most common malignancy associated with HIV infection and is considered ...
International audienceSince the advent of highly effective combined antiretroviral treatment (cART),...
As highly active antiretroviral therapy (HAART) is available for less than one million individuals w...
Kaposi's sarcoma (KS) is the most prevalent AIDS-associated tumour, occurring in 20-30% of HIV-1infe...
Until the 1980s, little attention had been accorded to endemic Kaposi's sarcoma (KS), a neoplasm not...
Kaposi's Sarcoma (KS) is a multicentric angioproliferative cancer of endothelial cells (ECs) caused ...
Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defin...
Kaposi's sarcoma (KS), Non-Hodgkin's lymphma (NHL) and invasive cervical cancer are considered AIDS-...
Kaposi's sarcoma (KS) is the most common cancer associated with AIDS. KS aetiology and pathogenesis ...
The long-term impact of highly active antiretroviral therapy (HAART) in AIDS patients with Kaposi's ...
Kaposi sarcoma (KS) is a malignancy of viral etiology whose course ranges from cutaneous limited les...
There is little published information on effective treatment of Kaposi’s sarcoma (KS) in children ...
The clinical response of AIDS-related Kaposi's sarcoma (KS) to highly active antiretroviral therapy ...
Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its appearance on t...
A 42-year-old heterosexual man presented with bluish-purple spots on his skin and in his mouth cavit...
Kaposi's sarcoma (KS) is the most common malignancy associated with HIV infection and is considered ...
International audienceSince the advent of highly effective combined antiretroviral treatment (cART),...
As highly active antiretroviral therapy (HAART) is available for less than one million individuals w...
Kaposi's sarcoma (KS) is the most prevalent AIDS-associated tumour, occurring in 20-30% of HIV-1infe...
Until the 1980s, little attention had been accorded to endemic Kaposi's sarcoma (KS), a neoplasm not...
Kaposi's Sarcoma (KS) is a multicentric angioproliferative cancer of endothelial cells (ECs) caused ...
Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defin...
Kaposi's sarcoma (KS), Non-Hodgkin's lymphma (NHL) and invasive cervical cancer are considered AIDS-...
Kaposi's sarcoma (KS) is the most common cancer associated with AIDS. KS aetiology and pathogenesis ...
The long-term impact of highly active antiretroviral therapy (HAART) in AIDS patients with Kaposi's ...
Kaposi sarcoma (KS) is a malignancy of viral etiology whose course ranges from cutaneous limited les...
There is little published information on effective treatment of Kaposi’s sarcoma (KS) in children ...
The clinical response of AIDS-related Kaposi's sarcoma (KS) to highly active antiretroviral therapy ...
Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its appearance on t...
A 42-year-old heterosexual man presented with bluish-purple spots on his skin and in his mouth cavit...